SNF residents avoid repeat hospitalization with nurse-led heart failure program
By
Alicia Lasek
Sep 03, 2021
Sixty days after admission, patients in the disease management program had a lower composite rate of rehospitalization, ED visits or mortality when compared with their peers who had usual care. The program...
Clinical briefs for Friday, Sept. 3
By
Alicia Lasek
Sep 03, 2021
New COVID test shortages and delays evoke comparisons to earlier pandemic days … COVID long-haulers at risk for substantial kidney decline … Half of COVID survivors have at least 1 symptom a year later:...
Pfizer, Merck start testing COVID prevention pills in late-stage trials
By
Alicia Lasek
Sep 02, 2021
The drugs, each given orally as a pill, would provide an unprecedented COVID-19 preventive medication option if brought to market.
Orthostatic intolerance common in post-acute patients, signaling need for clinical workup
By
Alicia Lasek
Sep 02, 2021
Older rehabilitation patients should be assessed for symptoms of orthostatic intolerance upon admission, a new study suggests.
FDA warns of heart-related events for arthritis drug Xeljanz and others in its class
By
Alicia Lasek
Sep 02, 2021
The agency is requiring a warning label on the arthritis and ulcerative colitis drugs Xeljanz and Xeljanz XR (tofacitinib) and two other drugs in this class, citing an increased risk of adverse health...
Clinical briefs for Thursday, Sept. 2
By
Alicia Lasek
Sep 02, 2021
American Nurses Association urges feds to declare nurse shortage a national crisis … CDC advisers: LTCF residents should be first among COVID booster recipients … Sweeping report on COVID’s risk...
Monoclonal antibody combo allows more high-risk Mayo Clinic patients to recover at home
By
Alicia Lasek
Sep 01, 2021
Over four weeks, COVID patients treated with Regeneron’s federally authorized antibody cocktail had significantly fewer hospitalizations than their untreated peers, the health system’s investigators...
Study pinpoints incontinence drugs linked to higher mortality risk in dementia patients
By
Alicia Lasek
Sep 01, 2021
The urinary drugs tolterodine and oxybutynin have high anticholinergic effects on cognition scores and are associated with 55% increased mortality risk, researchers say.
Clinical briefs for Wednesday, Sept. 1
By
Alicia Lasek
Sep 01, 2021
Physicians’ scores on a general knowledge exam were tied to inappropriate prescribing for seniors … Two senior leaders leave FDA over U.S. vaccine decision-making … More states to roll out digital...
Chronic kidney disease may be overdiagnosed in elderly; experts urge change
By
Alicia Lasek
Aug 31, 2021
Many elderly are being diagnosed and treated for a condition that will never cause symptoms or hasten death, a new study suggests. The current threshold for CKD diagnosis needs to change, investigators...